Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Hieronymus J. Derijks"'
Autor:
Loes J. M. van Herpen-Meeuwissen, Bart J. F. van den Bemt, Hieronymus J. Derijks, Patricia M. L. A. van den Bemt, Barbara Maat, Hein A. W. van Onzenoort
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Improving patient’s medication knowledge and consequently medication use is essential for optimal treatment outcomes. As patient knowledge about medication is currently suboptimal, interventions to optimise medication knowledge
Externí odkaz:
https://doaj.org/article/a973d6c881cc42708aade1aa6e16e1ae
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 9 (2017)
In this report we describe a 53-year-old woman with advanced non-small cell lung cancer, treated with pemetrexed and cisplatin combination therapy, followed by pemetrexed monotherapy. The patient developed severe muscle spasms at least twice, shortly
Externí odkaz:
https://doaj.org/article/9d7dcc29fe58411396a5363f08fa6f3f
Autor:
Jetske Graafsma, Joanna E Klopotowska, Hieronymus J Derijks, Ewoudt M W van de Garde, Rien H L Hoge, Marieke J H A Kruip, Karina Meijer, Fatma Karapinar-Carkit, Patricia M L A van den Bemt
Publikováno v:
PLoS ONE, Vol 19, Iss 6, p e0306033 (2024)
Antithrombotics require careful monitoring to prevent adverse events. Safe use can be promoted through so-called antithrombotic stewardship. Clinical decision support systems (CDSSs) can be used to monitor safe use of antithrombotics, supporting anti
Externí odkaz:
https://doaj.org/article/fb72e9f2b4574e468baef9ed9a092c6d
Autor:
Nikki de Rouw, René J. Boosman, Jacobus A. Burgers, Alwin D. R. Huitema, Anne-Marie C. Dingemans, Hieronymus. J. Derijks, David M. Burger, Berber Piet, Lizza E. L. Hendriks, Bonne Biesma, Melinda A. Pruis, Daphne W. Dumoulin, Sander Croes, Ron H. J. Mathijssen, Michel M. van den Heuvel, Rob ter Heine
Publikováno v:
Cancer Chemotherapy and Pharmacology, 91, 33-42
Cancer Chemotherapy and Pharmacology, 91(1), 33-42. Springer Verlag
Cancer Chemotherapy and Pharmacology, 91(1), 33-42. Springer-Verlag
Cancer Chemotherapy and Pharmacology, 91, 1, pp. 33-42
Cancer Chemotherapy and Pharmacology, 91(1), 33-42. Springer Verlag
Cancer Chemotherapy and Pharmacology, 91(1), 33-42. Springer-Verlag
Cancer Chemotherapy and Pharmacology, 91, 1, pp. 33-42
Item does not contain fulltext PURPOSE: Pemetrexed is a chemotherapeutic drug in the treatment of non-small cell lung cancer and mesothelioma. Optimized dosing of pemetrexed based on renal function instead of body surface area (BSA) is hypothesized t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f89d8fdab2aea47b4e702192ee6d7831
https://hdl.handle.net/2066/290955
https://hdl.handle.net/2066/290955
Autor:
Annemieke M, Anna Vermeulen Windsant-van den Tweel, Hieronymus J, Derijks, Nadine P P M, Gadiot, Carolina J P W, Keijsers
Publikováno v:
The Senior Care Pharmacist. 37:623-630
Purpose Proton pump inhibitors (PPIs) are prescribed frequently and can cause potentially severe hypomagnesemia. Researchers assessed the prevalence of hypomagnesemia and the association between PPI use and hypomagnesemia in hospitalized older patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8daa2fb84fb47ea39e97f6c04392201
https://doi.org/10.4140/tcp.n.2022.623
https://doi.org/10.4140/tcp.n.2022.623
Autor:
Rob ter Heine, Michel M. van den Heuvel, Berber Piet, Maarten J. Deenen, Anthonie J. van der Wekken, Lizza E. L. Hendriks, Sander Croes, Robin M. J. M. van Geel, Frank G. A. Jansman, Rogier C. Boshuizen, Eric J. F. Franssen, Arthur A. J. Smit, Daphne W. Dumoulin, Thijs H. Oude Munnink, Egbert F. Smit, Hieronymus J. Derijks, Cor H. van der Leest, Jeroen J. M. A. Hendrikx, Dirk J. A. R. Moes, Nikki de Rouw
Publikováno v:
Targeted Oncology, 18, 3, pp. 441-450
Targeted Oncology, 18(3), 441-450. Springer Paris
Targeted Oncology, 18, 441-450
Targeted Oncology, 18(3), 441-450. Springer Paris
Targeted Oncology, 18, 441-450
Contains fulltext : 292912.pdf (Publisher’s version ) (Open Access) BACKGROUND: Expensive novel anticancer drugs put a serious strain on healthcare budgets, and the associated drug expenses limit access to life-saving treatments worldwide. OBJECTIV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20b4dad43b54aa2ad8708876b6bbe71a
https://repository.ubn.ru.nl/handle/2066/292912
https://repository.ubn.ru.nl/handle/2066/292912
Autor:
Nikki, de Rouw, René J, Boosman, Jacobus A, Burgers, Alwin D R, Huitema, Anne-Marie C, Dingemans, Hieronymus J, Derijks, David M, Burger, Berber, Piet, Lizza E L, Hendriks, Bonne, Biesma, Melinda A, Pruis, Daphne W, Dumoulin, Sander, Croes, Ron H J, Mathijssen, Michel M, van den Heuvel, Rob, Ter Heine
Publikováno v:
Cancer chemotherapy and pharmacology. 91(1)
Pemetrexed is a chemotherapeutic drug in the treatment of non-small cell lung cancer and mesothelioma. Optimized dosing of pemetrexed based on renal function instead of body surface area (BSA) is hypothesized to reduce pharmacokinetic variability in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::08f2e0666f49f6f685f3d626007f6077
https://pubmed.ncbi.nlm.nih.gov/36413252
https://pubmed.ncbi.nlm.nih.gov/36413252
Autor:
Michel M van den Heuvel, David M. Burger, Rob ter Heine, Sabine Visser, Stijn L.W. Koolen, Joachim G.J.V. Aerts, Hieronymus J. Derijks, Nikki de Rouw
Publikováno v:
Cancer Chemotherapy and Pharmacology, 85, 231-235
Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy and Pharmacology, 85, 1, pp. 231-235
Cancer Chemotherapy and Pharmacology, 85, 231-235. Springer-Verlag
Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy and Pharmacology, 85, 1, pp. 231-235
Cancer Chemotherapy and Pharmacology, 85, 231-235. Springer-Verlag
Purpose Pemetrexed is a widely used cytostatic agent with an established exposure–response relationship. Although dosing is based on body surface area (BSA), large interindividual variability in pemetrexed plasma concentrations is observed. Therape
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e9c8e30d0284fa1a409d2b5bacf9f0a
https://hdl.handle.net/2066/218115
https://hdl.handle.net/2066/218115
Autor:
Nikki Rouw, Merel Boer, René J. Boosman, Michel M. Heuvel, David M. Burger, Joris E. Lieverse, Hieronymus J. Derijks, Geert W.J. Frederix, Rob Heine
Publikováno v:
Clinical Pharmacology and Therapeutics, 111, 1103-1110
Clinical Pharmacology and Therapeutics, 111, 5, pp. 1103-1110
Clinical Pharmacology and Therapeutics, 111, 5, pp. 1103-1110
Contains fulltext : 251211.pdf (Publisher’s version ) (Open Access) Neutropenia is a dose-related treatment-limiting and costly adverse event of pemetrexed. We postulate that individualized dosing reduces the incidence of neutropenia. The aims of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::252fd63663af5e8652acdd030f33c002
https://doi.org/10.1002/cpt.2529
https://doi.org/10.1002/cpt.2529
Autor:
Rene J. Boosman, Ron H.J. Mathijssen, Joachim G.J.V. Aerts, Hieronymus J. Derijks, Sander Croes, David M. Burger, Luuk B. Hilbrands, Stijn L.W. Koolen, Alwin D. R. Huitema, Michel M van den Heuvel, Jacobus A. Burgers, Lizza E.L. Hendriks, Rob ter Heine, Nikki de Rouw, Anne-Marie C. Dingemans, Bonne Biesma, Berber Piet
Publikováno v:
British Journal of Clinical Pharmacology, 88, 2, pp. 871-876
British Journal of Clinical Pharmacology, 88(2), 871-876. Wiley-Blackwell Publishing Ltd
British Journal of Clinical Pharmacology, 88(2), 871-876. Wiley
British Journal of Clinical Pharmacology, 88, 871-876
British Journal of Clinical Pharmacology, 88(2), 871-876. Wiley-Blackwell Publishing Ltd
British Journal of Clinical Pharmacology, 88(2), 871-876. Wiley
British Journal of Clinical Pharmacology, 88, 871-876
Contains fulltext : 249097.pdf (Publisher’s version ) (Open Access) Pemetrexed is a cytotoxic drug for first-line treatment of lung cancer. It is often combined with other anticancer drugs such as cisplatin or carboplatin. In clinical practice, hyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f536f1912b1695b5b2b04b0a78a0710